The United States recorded 45,242 new cases of COVID-19 on Friday – the largest single-day increase of the pandemic – according to a Reuters tally, bringing the total number of Americans who have tested positive to at least 2.48 million.
A review of some recently published scientific studies includes one for antihistamines and similar compounds that might slow down Huntington’s disease.
Shares of Orchard Therapeutics fell in trading after the company announced a new strategic plan that includes the shift in clinical focus, the shuttering of a proposed manufacturing facility in California and the termination of 25 percent of company staff.
Control Charts Best Method to Identify Real Improvements SEATTLE, April 8, 2020 /PRNewswire/ — MDmetrix, a clinical performance management platform, today announced it has developed new control charts that […]
As a critical industry during the COVID-19 pandemic, biopharma companies are expected to remain in operation – but with a skeleton staff. Anticipating stay-at-home mandates, life sciences companies and labs in especially hard-hit regions had already begun preparing.
California ordered nearly 40 million people to stay home and New York state on Friday told all non-essential workers to do the same while pleading for more medical personnel and supplies to treat coronavirus cases that could overwhelm hospitals.
The U.S. death toll from coronavirus infections rose as new cases emerged around New York City and Los Angeles, while Seattle-area health officials discouraged social gatherings amid the nation’s largest outbreak.
A look at how the California Consumer Privacy Act put into effect in 2020 will impact the pharmaceutical industry.
Civica Rx and 18 independent Blue Cross and Blue Shield (BCBS) companies formed a new subsidiary dedicated to lowering the cost of select generic drugs.
By David Reim, Chief Privacy Officer at DMD The California Consumer Privacy Act (CCPA) is now the law of the land. California is home to 12% of the country’s consumers, […]
